Skip to content

Vitamin D Supplement Study for Adolescents

V.I.P. Feasibility Study (Vitamin D Intake Project)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00909454
Acronym
VIP
Enrollment
45
Registered
2009-05-28
Start date
2009-02-28
Completion date
2009-06-30
Last updated
2011-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Overweight, Vitamin D Deficiency

Keywords

Vitamin D deficiency, Adolescents, African Americans, Overweight, Obesity

Brief summary

The purpose of this study is to determine if 14-19 year old African American adolescents are able to take a daily vitamin D supplement daily for about 4 months and how well a daily dose of 400 IU or 2000 IU vitamin D supplement raises their vitamin D blood level.

Detailed description

To determine the feasibility of African American teenagers taking a daily vitamin D supplement over a 4 month period in terms of compliance and practical implementation. To determine the differences in response in blood 25-OH D level between those randomly assigned to taking a 400 IU supplement versus 2000 IU per day and to determine if there are differences in blood 25-OH D level response depending on subject gender and overweight/obese versus healthy-weight status.

Interventions

DIETARY_SUPPLEMENT2000 IU Vitamin D3 daily supplement

2000 IU vitamin D3 supplement to be taken once daily over 4 months

DIETARY_SUPPLEMENT400 IU Vitamin D3 supplement

400 IU Vitamin D3 supplement to be taken daily over 4 months

Sponsors

Augusta University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
14 Years to 19 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy African American Adolescents

Exclusion criteria

* Hypertension * Pregnancy * Medications that affect study outcome measures * Use of other vitamin and/or mineral supplement or herbal supplements * Individuals of other races

Design outcomes

Primary

MeasureTime frame
Plasma 25-OH D level3-4 months from baseline to post-testing

Secondary

MeasureTime frame
Blood pressure3-4 months from baseline to post-testing

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026